Evidence map›Paper›PMID 27325407›Full record

ReviewGlycoconjugate journal2017

Glycosphingolipids of human embryonic stem cells.

Michael E Breimer, Karin Säljö, Angela Barone, Susann Teneberg

Open access · hybridAbstract readReview
In one paragraph

Review in Glycoconjugate journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Virulence · 2022
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Lipid composition of the cancer cell membrane.Journal of bioenergetics and biomembranes · 2020
    Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Michael E BreimerInstitute of Clinical Sciences, Department of Surgery, Sahlgrenska Academy at University of Gothenburg, Göteborg, Sweden.
Karin SäljöInstitute of Clinical Sciences, Department of Surgery, Sahlgrenska Academy at University of Gothenburg, Göteborg, Sweden.
Angela BaroneInstitute of Biomedicine, Department of Medical Biochemistry and Cell Biology, Sahlgrenska Academy at University of Gothenburg, P.O. Box 440, S-405 30, Göteborg, Sweden.
Susann TenebergInstitute of Biomedicine, Department of Medical Biochemistry and Cell Biology, Sahlgrenska Academy at University of Gothenburg, P.O. Box 440, S-405 30, Göteborg, Sweden. Susann.Teneberg@medkem.gu.se.
University of Gothenburg · SE

Funding

Vetenskapsrådet 12628
6 · The paper itself

Abstract

The application of human stem cell technology offers theoretically a great potential to treat various human diseases. However, to achieve this goal a large number of scientific issues remain to be solved. Cell surface carbohydrate antigens are involved in a number of biomedical phenomena that are important in clinical applications of stem cells, such as cell differentiation and immune reactivity. Due to their cell surface localization, carbohydrate epitopes are ideally suited for characterization of human pluripotent stem cells. Amongst the most commonly used markers to identify human pluripotent stem cells are the globo-series glycosphingolipids SSEA-3 and SSEA-4. However, our knowledge regarding human pluripotent stem cell glycosphingolipid expression was until recently mainly based on immunological assays of intact cells due to the very limited amounts of cell material available. In recent years the knowledge regarding glycosphingolipids in human embryonic stem cells has been extended by biochemical studies, which is the focus of this review. In addition, the distribution of the human pluripotent stem cell glycosphingolipids in human tissues, and glycosphingolipid changes during human stem cell differentiation, are discussed.

Indexed as

Blood Group AntigensEmbryonic Stem CellsGlycosphingolipidsHumansStage-Specific Embryonic AntigensBlood Group AntigensGlycosphingolipidsStage-Specific Embryonic AntigensBlood group antigensGlycosphingolipid characterizationHuman embryonic stem cellsHuman induced pluripotent stem cellsHuman pluripotent stem cellsMass spectrometryStem cell marker

Identifiers

PMID27325407
PMCPMC5711972
OpenAlexW2471222274

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.